A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.
about
Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cellsThe human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portionsMolecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicityHuman natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B allelesPolymorphism and domain variability of human killer cell inhibitory receptorsNKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysisp46, a novel natural killer cell-specific surface molecule that mediates cell activationIdentification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cellsMechanism of target cell recognition by natural killer cells: characterization of a novel triggering molecule restricted to CD3- large granular lymphocytesThe natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimerThe evolution of natural killer cell receptorsTrachoma and Ocular Chlamydial Infection in the Era of GenomicsCurrent perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptorsAmino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clonesDifferential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptorsCan Selective MHC Downregulation Explain the Specificity and Genetic Diversity of NK Cell Receptors?Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects.Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells.KIR/HLA interactions and pathogen immunityLinker for activation of T cells (LAT), a novel immunohistochemical marker for T cells, NK cells, mast cells, and megakaryocytes: evaluation in normal and pathological conditions.Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humansInvolvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2)Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells.Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements.Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705.Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases.Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology.Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones.Activating killer cell Ig-like receptors in health and disease.The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.Human NK receptors: from the molecules to the therapy of high risk leukemias.At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies.At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Human NK cells: from surface receptors to the therapy of leukemias and solid tumorsThe early days of NK cells: an example of how a phenomenon led to detection of a novel immune receptor system - lessons from a rat modelKIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing.Markers and function of human NK cells in normal and pathological conditions.Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors.
P2860
Q22010576-A1D26276-6CC5-467E-8646-67B66F5A76DBQ24310543-45798129-080B-43C2-9A05-5A2EBB557E77Q24310824-722A05C4-DADD-4881-AD7B-361E597590FDQ24315770-9734E610-1F26-468B-992A-F554B2FFF4FEQ24329103-C832F65B-BE57-4F5E-8F7A-EA3760CC15F1Q24647094-7405EA7C-7631-41E3-BA97-5BC1AFFAE062Q24647847-DBDE0BD2-DF13-41AE-9DB9-1765839B3EBDQ24671834-1F7F1542-A190-4171-9235-968FC1198272Q24675597-F21135A2-2564-4D83-84B4-D6017844F7DAQ24677386-C4DED3A9-4203-4328-8242-404308CFB733Q26782592-55B50223-E2CC-481F-AD83-9B5F2E5F3449Q26783635-974EC9EC-7DC8-4230-84E6-8C2E90FA1B98Q27009135-DDE82615-20C0-4E86-B1E7-39AD3BE91D52Q28610595-6506DCA0-3408-468B-A43E-D62BCE8A8669Q28776435-4ABFB812-3340-43BC-A369-4B85D590AC81Q30654514-DD158094-EABB-457D-8D26-2FCAD98F11D1Q31145728-6E2107C6-5327-422E-8193-F65CFB720EDBQ34452527-2BEEB6F3-FBE6-4E48-B071-135DF9687C32Q35001169-8ECC9BFB-554B-4E4A-94A2-BBFB29DDEFE9Q35786835-24CC04EC-135B-444C-B784-136511B3D6D8Q36231084-15DE5922-A184-4B06-B1DE-0ECEF46E825BQ36231811-E3B1AAE0-59DA-4B1B-AF53-4066BC53E8C9Q36361022-E235ED0C-EDBE-49A4-8361-4CE9439A8AF1Q36362289-8AB654BD-E0E9-4FD0-8D64-C1D8123817EEQ36365713-C72D5C81-0AD6-456C-B41C-01C17A6CF3CBQ36367408-296BD914-6948-4DE9-8592-EF2BE9C84D20Q36380459-766366EB-5AFB-40A7-A9FC-21753632B23EQ36407362-418D80F7-2CF5-414E-99EA-53F7976C5410Q37622486-7C2EC21C-2259-4218-B1EB-2B1DE8C26C76Q37717176-606BC09F-06C8-4C7C-AB49-DCE5A60F9A0CQ37725657-3C069095-80B0-434D-9084-50ECBDCB1A5DQ37781088-39ADB2C3-083A-4D87-AECD-CAE9AED2343FQ37873594-C0CA00F6-4B00-4001-8DEE-16FC5FE88A1EQ38149725-1EB267B7-80E2-4E68-8496-D3FA43A3D125Q38151057-74840001-EF03-453D-897E-BBC3D0A7C20FQ38196803-280037C6-5467-48D6-9993-E77594A007C1Q38225120-7908AA77-3B94-40B4-AD74-36A2CEF1BF38Q38731024-CBC32B99-114D-42F2-A808-1031FC803F58Q39068084-96C4CB10-7D88-415B-898B-B892B93763D4Q40790182-ACA59420-F5CC-4CC5-A10A-856B1232A74E
P2860
A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
A novel surface antigen expres ...... ulation of cytolytic function.
@ast
A novel surface antigen expres ...... ulation of cytolytic function.
@en
type
label
A novel surface antigen expres ...... ulation of cytolytic function.
@ast
A novel surface antigen expres ...... ulation of cytolytic function.
@en
prefLabel
A novel surface antigen expres ...... ulation of cytolytic function.
@ast
A novel surface antigen expres ...... ulation of cytolytic function.
@en
P2093
P2860
P356
P1476
A novel surface antigen expres ...... ulation of cytolytic function.
@en
P2093
Tambussi G
P2860
P304
P356
10.1084/JEM.171.3.695
P407
P577
1990-03-01T00:00:00Z